Contact
Please use this form to send email to PR contact of this press release:
Opinion/decision on a Paediatric investigation plan (PIP): 2-{4-[4-(4-{5-[(1S)-1-amino-1-(4-fluorophenyl) ethyl]pyrimidin-2-yl}piperazin-1-yl)pyrrolo[2,1-f] [1,2,4]triazin-6-yl]-1H-pyrazol-1-yl}ethan-1-ol, decision type: , therapeutic area: , PIP…
TO: